Skip to main content
SpringerLink
Log in

Bladder cancer and black tobacco cigarette smoking

Some results from a French case-control study

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

A retrospective study was planned in the Hérault (Mediterranean) region of France where bladder cancer mortality and incidence rates are high. In the present paper, variations in bladder cancer risk according to various smoking-related variables, in particular time of exposure and type of tobacco, are examined. This case-control study with 219 male incident cases and 794 male population controls randomized from electoral rolls was carried out in 1987–89. Trained interviewers obtained information on demographics, dietary habits (coffee, alcohol, artificial sweeteners, vegetables, spices, etc.), occupational exposures and detailed history of tobacco smoking (average number of cigarettes per day, number of years of smoking, age at which they began and/or quitted smoking, use of filter-tip and type of tobacco). The odds ratio (OR) for cigarette smokers versus non-smokers was greater than 5. Results for number of cigarettes daily, duration of smoking and lifetime smoking showed a highly significant dose-response relationship, which was confirmed when these variables were treated as continuous in a logistic regression model. Eighty-eight percent of the smokers used black tobacco. Quitting smoking did not result in a significant reduction in bladder cancer risk. Higher risks were associated with starting to smoke at an early age (OR before age 13 versus after age 21=3.42; 95% CI 1.07–10.9) and with black tobacco smoking (OR black versus blond =1.63; 95% CI 0.73–3.64). Results suggest that black tobacco may be more harmful than blond tobacco and may have an early non-reversible role in bladder carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cartwright RA, Adib R, Appleyard I, Glashan RW, Gray B, Hamilton-Stewart PA, Robinson M, Barham-Hall D. Cigarette smoking and bladder cancer: An epidemiological inquiry in West Yorkshire. J Epidemiol Community Health 1983; 37: 256–263.

    Google Scholar 

  2. Clavel J, Cordier S, Boccon-Gibod L, Hemon D. Tobacco and bladder cancer in males: Increased risk for inhalers and smokers of black tobacco. Int J Cancer 1989; 44: 605–610.

    Google Scholar 

  3. Cole P, Monson RP, Haning H, Friedell GH. Smoking and cancer of the lower urinary tract. N Engl J Med 1971; 284: 129–134.

    Google Scholar 

  4. Hartge P, Silverman D, Hoover R, Schairer C, Altman R, Austin D, Cantor K, Child M, Key C, Marrett LD, Mason TJ, Meigs JW, Myers MH, Narayana A, Sullivan JW, Swanson GM, Thomas D, West D. Changing cigarette habits and bladder cancer risk: a case-control study. J Natl Cancer Inst 1987; 78: 1119–1125.

    Google Scholar 

  5. Howe GR, Burch JD, Miller AB, Cook GM, Esteve J, Morrison B, Gordon P, Chambers LW, Fodor G, Winsor GM. Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst 1980; 64: 701–713.

    Google Scholar 

  6. Iscovich J, Castelletto R, Esteve J, Munoz N, Colanzi R, Coronel A, Deamezola I, Tassi V, Arslan A. Tobacco smoking, occupational exposure and bladder cancer in Argentina. Int J Cancer 1987; 40: 734–740.

    Google Scholar 

  7. Lopez-Abente G, Gonzalez GA, Errezola M, Escolar A, Izarzugaza I, Nebot M, Riboli E. Tobacco smoke inhalation pattern, tobacco type and bladder cancer in Spain. Am J Epidemiol 1991; 134: 830–839.

    Google Scholar 

  8. Miller CT, Neutel CI, Nair RC, Marrett LD, Last JM, Collins WE. Relative importance of risk factors in bladder carcinogenesis. J Chron Dis 1978; 31: 51–56.

    Google Scholar 

  9. Mommsen S, Aagaard J. Tobacco as a risk factor in bladder cancer. Carcinogenesis 1983; 4: 335–338.

    Google Scholar 

  10. Morgan RW, Jain MG. Bladder cancer: smoking, beverages and artificial sweeteners. Can Med Assoc J 1974; 111: 1067–1069.

    Google Scholar 

  11. Morrison AS, Buring JE, Verhoek WG, Aoki K, Leck I, Ohno Y, Obata K. An international study of smoking and bladder cancer. J Urol 1984; 131: 650–654.

    Google Scholar 

  12. Rebelakos A, Trichopoulos D, Tzonou A, Zavitsanos X, Velonakis E, Trichopoulos A. Tobacco smoking, coffee drinking, and occupation as risk factors for bladder cancer in Greece. J Natl Cancer Inst 1985; 75: 455–461.

    Google Scholar 

  13. Vineis P, Esteve J, Hartge P, Hoover R, Silverman DT, Terracini B. Effects of timing and type of tobacco in cigarettes-induced bladder cancer. Cancer Res 1988; 48: 3849–3852.

    Google Scholar 

  14. Vineis P, Esteve J, Terracini B. Bladder cancer and smoking in males: types of interaction with occupation. Int J Cancer 1984; 34: 165–170.

    Google Scholar 

  15. Vineis P, Frea B, Uberti E, Ghisetti V, Terracini B. Bladder cancer and cigarette smoking in males: A case-control study. Tumori 1983; 69: 17–22.

    Google Scholar 

  16. Wynder EL, Augustine A, Kabat GC. Effect of the type of cigarette smoked on bladder cancer risk. Cancer 1988; 61: 622–627.

    Google Scholar 

  17. Wynder EL, Goldsmith RS. The epidemiology of bladder cancer. Cancer 1977; 40: 1246–1268.

    Google Scholar 

  18. Rezvani A, Doyon F, Flamant R. Atlas de la mortalité par cancer en France (1971–1978). Paris (France): Editions INSERM, 1986.

    Google Scholar 

  19. Stoebner A, Daures JP. Le cancer de la vessie dans l'H érault 1986–1988 — Registre des cancers de l'Hérault. Montpellier (France): Editions P. Fabre 1991.

    Google Scholar 

  20. Momas I. Epidémiologie du cancer de la vessie dans l'Hérault: Enquěte cas-témoins. Thése de Doctorat de l'Université de Montpellier I, France, 1990.

  21. Momas I, Daures JP, Gremy F. Quels témoins choisir dans une étude cas-témoin? Enquête sur le cancer vésical dans l'Hérault. Rev Epidém Santé Publ 1991; 39: 197–207.

    Google Scholar 

  22. Stepney R. Are smokers' self-reports of inhalation a useful measure of smoke exposure? J Epidemiol Community Health 1982; 36: 109–112.

    Google Scholar 

  23. Breslow NE, Day NE. Statistical methods in cancer research. IARC Scientific Publication 32. 1980. Lyon: IARC.

    Google Scholar 

  24. Vineis P. Black (air-cured) and blond (flue-cured) tobacco and cancer risk, I: Bladder cancer. Eur J Cancer 1991; 27: 1491–1493.

    Google Scholar 

  25. Bryant MS, Vineis P, Skipper PL, Tannenbaum SR. Hemoglobin adducts of aromatic amines: Associations with smoking status and type of tobacco. Proc Nat Acad Sci (Wash) 1988; 85: 9788–9791.

    Google Scholar 

  26. Mohtashamipur E, Norpoth K, Lieder F. Urinary excretion of mutagens in smokers of cigarettes with various tar and nicotine yields, black tobacco, and cigars. Cancer Lett 1987; 34: 103–112.

    Google Scholar 

  27. Brown C, Chu KC. Use of multistage models to infer stage affected by carcinogenic exposure: Example of lung cancer and cigarette smoking. J Chron Dis 1987; 40 (Suppl 2): 171s-179s.

    Google Scholar 

  28. Doll R. An epidemiological perspective of the biology of cancer. Cancer Res 1978; 38: 3573–3583.

    Google Scholar 

  29. Weinstein B. The origins of human cancer: Molecular mechanisms of carcinogenesis and their applications for cancer prevention and treatment. 27th G.H.A. Howes Memorial Award Lecture. Cancer Res 1988; 48: 4135–4143.

    Google Scholar 

  30. Foiles PG, Akerkar SA, Carmella SG. Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. Chem Res Toxicol 1991; 4: 364–368.

    Google Scholar 

  31. Cohen SM. Urinary bladder carcinogenesis: Initiation-promotion. Seminars in Oncology 1979; 6: 157–180.

    Google Scholar 

  32. Bartsch H, Malaveille C, Friesen M, Kadlubar FF, Vineis P. Black (air-cured) and Blond (flue-cured) tobacco cancer risk, IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer 1993; 29A: 1199–1207.

    Google Scholar 

  33. Cartwright RA. Occupational bladder cancer cigarette smoking in West Yorkshire. Scand J Work Environ Health 1982; 8 (suppl 1): 79–82.

    Google Scholar 

  34. Decarli A, Peto J, Piolatto G. Bladder cancer mortality of workers exposed to aromatic amines: Analysis of models of carcinogenesis. Br J Cancer 1985; 51: 707–712.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département de l'Information Médicale, Hôpital Lapeyronie, Montpellier, France

    I. Momas & F. Gremy

  2. Laboratoire d'Hygiéne et de Santé Publique, Faculté des Sciences Pharmaceutiques et Biologiques, 4 avenue de l'Observatoire, F-75 270, Paris, France

    I. Momas & B. Festy

  3. Département de l'Information Médicale, Hôpital Caremeau, Nîmes, France

    J. P. Daures

  4. Département ‘Sciences de l'Environnement et Santé Publique ’, Faculté de Pharmacie, Montpellier, France

    J. Bontoux

Authors
  1. I. Momas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. P. Daures
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Festy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Bontoux
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Gremy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Momas, I., Daures, J.P., Festy, B. et al. Bladder cancer and black tobacco cigarette smoking. Eur J Epidemiol 10, 599–604 (1994). https://doi.org/10.1007/BF01719579

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01719579

Key words

Search

Navigation